Galectin Therapeutics
GALT
#8191
Rank
NZ$0.29 B
Marketcap
$4.66
Share price
-3.37%
Change (1 day)
44.55%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$1.08

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.13. In 2022 the company made an earnings per share (EPS) of -$1.11 a decrease over its 2021 EPS that were of -$0.89.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.08-3.15%
2022-$1.1125%
2021-$0.8930%
2020-$0.68-6.98%
2019-$0.7413.16%
2018-$0.65-22.45%
2017-$0.84-35.53%
2016-$1.30-13.64%
2015-$1.5111.39%
2014-$1.35-39.69%
2013-$2.2481.94%
2012-$1.23-32.08%
2011-$1.817.07%
2010-$1.69-17.5%
2009-$2.05150%
2008-$0.82-68%
2007-$2.57127.27%
2006-$1.13-52.17%
2005-$2.36-20.69%
2004-$2.9852.63%
2003-$1.95-13.64%
2002-$2.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$21.94 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.33-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA